secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2026-05-15T20:00:10+00:00
Accession:  0001628280-26-035535
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience receives Nasdaq delisting notice for failing minimum stockholders' equity
--------------------------------------------------------------------------------

- Stockholders' equity was $9,011,804, below Nasdaq Global Market's $10M minimum requirement.
- Nasdaq gave 45 days (until June 29, 2026) to submit a compliance plan; extension possible to Nov 9, 2026.
- No immediate impact on trading; stock continues to trade under 'SKYE'.
- Company is evaluating alternative courses of action to regain compliance; no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000162828026035535/0001628280-26-035535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000162828026035535/skye-20260513.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-035535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer